These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 22937579)
1. [Morphological, immunohistochemical and radiological manifestation of lung tissue remodeling at lung sarcoidosis]. Kogan EA; Kichigina ON; Demura SA; Osipenko VI Arkh Patol; 2012; 74(3):37-43. PubMed ID: 22937579 [TBL] [Abstract][Full Text] [Related]
2. Metalloproteinases MMP-9, MMP-2 and their tissue inhibitors TIMP-1, TIMP-2 in peripheral transbronchial lung biopsies of patients with sarcoidosis. Piotrowski WJ; Nawrocka-Kunecka A; Antczak A; Marczak J; Biernacki R; Kordek P; Kurmanowska Z; Górski P Pol Arch Med Wewn; 2009 Oct; 119(10):628-35. PubMed ID: 19847138 [TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases and their tissue inhibitors in the lesions of cardiac and pulmonary sarcoidosis: an immunohistochemical study. González AA; Segura AM; Horiba K; Qian S; Yu ZX; Stetler-Stevenson W; Willerson JT; McAllister HA; Ferrans VJ Hum Pathol; 2002 Dec; 33(12):1158-64. PubMed ID: 12514782 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical localization of transforming growth factor-beta 1 in the nonnecrotizing granulomas of pulmonary sarcoidosis. Limper AH; Colby TV; Sanders MS; Asakura S; Roche PC; DeRemee RA Am J Respir Crit Care Med; 1994 Jan; 149(1):197-204. PubMed ID: 8111583 [TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF. Henry MT; McMahon K; Mackarel AJ; Prikk K; Sorsa T; Maisi P; Sepper R; Fitzgerald MX; O'Connor CM Eur Respir J; 2002 Nov; 20(5):1220-7. PubMed ID: 12449177 [TBL] [Abstract][Full Text] [Related]
6. [Granulomatous diseases and pathogenic microorganism]. Inoue Y; Suga M Kekkaku; 2008 Feb; 83(2):115-30. PubMed ID: 18326339 [TBL] [Abstract][Full Text] [Related]
7. Reduced pulmonary function is associated with enhanced inflammation and tissue inhibitor of metalloproteinase 1 concentration in the bronchoalveolar lavage fluid of patients with lung parenchymal sarcoidosis. Shimada A; Koga T; Oshita Y; Hanada M; Nagafuchi Y; Aizawa H Kurume Med J; 2008; 55(1-2):13-7. PubMed ID: 18981680 [TBL] [Abstract][Full Text] [Related]
13. Manganese superoxide dismutase, but not CuZn superoxide dismutase, is highly expressed in the granulomas of pulmonary sarcoidosis and extrinsic allergic alveolitis. Lakari E; Pääkkö P; Kinnula VL Am J Respir Crit Care Med; 1998 Aug; 158(2):589-96. PubMed ID: 9700139 [TBL] [Abstract][Full Text] [Related]
14. [Molecular bases for the development of variants of idiopathic fibrosing alveolitis]. Kogan EA; Tyong FV; Demura SA Arkh Patol; 2009; 71(1):12-8. PubMed ID: 19514352 [TBL] [Abstract][Full Text] [Related]
16. Pulmonary granulomatous inflammation: From sarcoidosis to tuberculosis. Perez RL; Rivera-Marrero CA; Roman J Semin Respir Infect; 2003 Mar; 18(1):23-32. PubMed ID: 12652451 [TBL] [Abstract][Full Text] [Related]
17. Mathematical model of sarcoidosis. Hao W; Crouser ED; Friedman A Proc Natl Acad Sci U S A; 2014 Nov; 111(45):16065-70. PubMed ID: 25349384 [TBL] [Abstract][Full Text] [Related]
18. Occurrence of lung granulomas in patients with stage I sarcoidosis. Rosen Y; Amorosa JK; Moon S; Cohen J; Lyons HA AJR Am J Roentgenol; 1977 Dec; 129(6):1083-5. PubMed ID: 413363 [TBL] [Abstract][Full Text] [Related]
19. Molecular Mechanism in the Development of Pulmonary Fibrosis in Patients with Sarcoidosis. Cocconcelli E; Bernardinello N; Castelli G; Petrarulo S; Bellani S; Saetta M; Spagnolo P; Balestro E Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445947 [TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease. Ulrich D; Hrynyschyn K; Pallua N Plast Reconstr Surg; 2003 Oct; 112(5):1279-86. PubMed ID: 14504511 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]